Maximum quantity allowed is 999
Please select the quantity
CAS RN: 242478-38-2 | Product Number: S0944
Solifenacin Succinate

Purity: >98.0%(HPLC)
Synonyms:
Product Documents:
* The above prices include freight cost, customs, and other charges to the destination except for products that need to be shipped by sea or dry ice. For details, please contact
our distributor
in Taiwan to order our product.
* The storage conditions are subject to change without notice.
Product Number | S0944 |
Purity / Analysis Method | >98.0%(HPLC) |
Molecular Formula / Molecular Weight | C__2__3H__2__6N__2O__2·C__4H__6O__4 = 480.56 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
Packaging and Container | 100MG-Glass Bottle with Plastic Insert (View image) |
CAS RN | 242478-38-2 |
Related CAS RN | 242478-37-1 |
PubChem Substance ID | 253662487 |
Merck Index (14) | 8712 |
MDL Number | MFCD09952287 |
Specifications
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 %(total of Ion-Pair) |
Melting point | 145.0 to 149.0 °C |
Properties (reference)
Melting Point | 147 °C |
Solubility (slightly sol. in) | Ethanol |
GHS
Pictogram |
![]() |
Signal Word | Warning |
Hazard Statements | H302 : Harmful if swallowed. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
Related Laws:
RTECS# | NW7136000 |
Transport Information:
H.S.code* | 2933.99-000 |
Application
Solifenacin Succinate: Selective M3 Muscarinic Receptor Antagonist
Solifenacin succinate is a selective M3 muscarinic receptor antagonist. It is used for the treatment of overactive bladder (OAB). For your reference, [P2215] is a key synthetic intermediate of solifenacin succinate. (The product is for research purpose only.)
References
- M3 receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland
- In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in rats
- Comparison of in vitro selectivity profiles of solifenacin succinate (YM905) and current antimuscarinic drugs in bladder and salivary glands: a Ca2+ mobilization study in monkey cells
- Synthesis and Antimuscarinic Properties of Quinuclidin-3-yl 1,2,3,4-Tetrahydroisoquinoline-2-carboxylate Derivatives as Novel Muscarinic Receptor Antagonists
- Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.